BIOGY
Price
$11.46
Change
+$0.46 (+4.18%)
Updated
Sep 24 closing price
Capitalization
1.16B
BIOYF
Price
$8.39
Change
-$0.11 (-1.29%)
Updated
Sep 26 closing price
Capitalization
95.29M
Interact to see
Advertisement

BIOGY vs BIOYF

Header iconBIOGY vs BIOYF Comparison
Open Charts BIOGY vs BIOYFBanner chart's image
Biogaia AB
Price$11.46
Change+$0.46 (+4.18%)
Volume$29K
Capitalization1.16B
BioSyent
Price$8.39
Change-$0.11 (-1.29%)
Volume$160
Capitalization95.29M
BIOGY vs BIOYF Comparison Chart in %
Loading...
BIOGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIOYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIOGY vs. BIOYF commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOGY is a Hold and BIOYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (BIOGY: $11.46 vs. BIOYF: $8.39)
Brand notoriety: BIOGY and BIOYF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BIOGY: 1010% vs. BIOYF: 10%
Market capitalization -- BIOGY: $1.16B vs. BIOYF: $95.29M
BIOGY [@Pharmaceuticals: Generic] is valued at $1.16B. BIOYF’s [@Pharmaceuticals: Generic] market capitalization is $95.29M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOGY’s FA Score shows that 2 FA rating(s) are green whileBIOYF’s FA Score has 1 green FA rating(s).

  • BIOGY’s FA Score: 2 green, 3 red.
  • BIOYF’s FA Score: 1 green, 4 red.
According to our system of comparison, BIOGY is a better buy in the long-term than BIOYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOGY’s TA Score shows that 4 TA indicator(s) are bullish while BIOYF’s TA Score has 5 bullish TA indicator(s).

  • BIOGY’s TA Score: 4 bullish, 3 bearish.
  • BIOYF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BIOGY and BIOYF are a good buy in the short-term.

Price Growth

BIOGY (@Pharmaceuticals: Generic) experienced а +11.80% price change this week, while BIOYF (@Pharmaceuticals: Generic) price change was -2.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIOGY($1.16B) has a higher market cap than BIOYF($95.3M). BIOGY has higher P/E ratio than BIOYF: BIOGY (38.09) vs BIOYF (16.42). BIOGY YTD gains are higher at: 22.631 vs. BIOYF (9.781). BIOGY has higher annual earnings (EBITDA): 393M vs. BIOYF (12M). BIOGY has more cash in the bank: 622M vs. BIOYF (20.4M). BIOGY has higher revenues than BIOYF: BIOGY (1.44B) vs BIOYF (39.5M).
BIOGYBIOYFBIOGY / BIOYF
Capitalization1.16B95.3M1,213%
EBITDA393M12M3,275%
Gain YTD22.6319.781231%
P/E Ratio38.0916.42232%
Revenue1.44B39.5M3,646%
Total Cash622M20.4M3,049%
Total DebtN/A942K-
FUNDAMENTALS RATINGS
BIOGY vs BIOYF: Fundamental Ratings
BIOGY
BIOYF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
7148
SMR RATING
1..100
4342
PRICE GROWTH RATING
1..100
4258
P/E GROWTH RATING
1..100
2160
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIOGY's Valuation (8) in the null industry is in the same range as BIOYF (26). This means that BIOGY’s stock grew similarly to BIOYF’s over the last 12 months.

BIOYF's Profit vs Risk Rating (48) in the null industry is in the same range as BIOGY (71). This means that BIOYF’s stock grew similarly to BIOGY’s over the last 12 months.

BIOYF's SMR Rating (42) in the null industry is in the same range as BIOGY (43). This means that BIOYF’s stock grew similarly to BIOGY’s over the last 12 months.

BIOGY's Price Growth Rating (42) in the null industry is in the same range as BIOYF (58). This means that BIOGY’s stock grew similarly to BIOYF’s over the last 12 months.

BIOGY's P/E Growth Rating (21) in the null industry is somewhat better than the same rating for BIOYF (60). This means that BIOGY’s stock grew somewhat faster than BIOYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOGYBIOYF
RSI
ODDS (%)
Bearish Trend 3 days ago
32%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
48%
Bullish Trend 3 days ago
41%
Momentum
ODDS (%)
Bullish Trend 3 days ago
31%
Bearish Trend 3 days ago
40%
MACD
ODDS (%)
Bullish Trend 3 days ago
28%
Bearish Trend 3 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
35%
Bearish Trend 3 days ago
37%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
33%
Bearish Trend 3 days ago
40%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
46%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
40%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
40%
Bullish Trend 3 days ago
73%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
BIOGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIOYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTAX32.200.85
+2.71%
Fidelity Advisor Biotechnology A
FIZRX37.360.54
+1.47%
Macquarie Opportunity R
RYEUX120.011.33
+1.12%
Rydex Europe 1.25x Strategy H
VSIEX22.650.25
+1.12%
JPMorgan International Equity I
DHIYX20.950.10
+0.48%
Diamond Hill International Y

BIOGY and

Correlation & Price change

A.I.dvisor tells us that BIOGY and SCYX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOGY and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOGY
1D Price
Change %
BIOGY100%
N/A
SCYX - BIOGY
21%
Poorly correlated
-0.46%
CANN - BIOGY
9%
Poorly correlated
+2.15%
BKUH - BIOGY
1%
Poorly correlated
N/A
BIOYF - BIOGY
1%
Poorly correlated
-1.29%
BOIRF - BIOGY
0%
Poorly correlated
N/A
More

BIOYF and

Correlation & Price change

A.I.dvisor tells us that BIOYF and AVCNF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOYF and AVCNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOYF
1D Price
Change %
BIOYF100%
-1.29%
AVCNF - BIOYF
9%
Poorly correlated
+4.68%
BUDZ - BIOYF
7%
Poorly correlated
+8.33%
BIOVF - BIOYF
7%
Poorly correlated
N/A
BIOGY - BIOYF
1%
Poorly correlated
N/A
BKUH - BIOYF
-1%
Poorly correlated
N/A
More